ECM
HALO icon

EMC Capital Management’s Halozyme HALO Stock Holding History

EMC Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$238K Sell
3,532
-623
-15% -$41.9K 0.11% 57
2025
Q3 		$305K Hold
4,155
– – 0.14% 39
2025
Q2 		$216K Buy
+4,155
New +$236K 0.12% 69

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EMC Capital Management's HALO Position: Q4 2025 in Review

EMC Capital Management reduced its Halozyme (HALO) stake by 15% in Q4 2025, selling an estimated $41.9K and leaving 3,532 shares worth $238K. The position accounts for 0.11% of the portfolio, ranked #57.

EMC Capital Management first reported a position in HALO in Q2 2025 and has held it in 3 quarters since. The position peaked at $305K in Q3 2025. 618 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • EMC Capital Management held 3,532 shares of Halozyme worth $238K as of Q4 2025.
  • EMC Capital Management sold 623 Halozyme shares in Q4 2025, an estimated $41.9K.
  • Halozyme made up 0.11% of EMC Capital Management's portfolio in Q4 2025, its #57 holding.
  • EMC Capital Management first reported a position in Halozyme in Q2 2025 and has held it in 3 quarters since.
  • EMC Capital Management's Halozyme position peaked at $305K in Q3 2025.
  • 618 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on EMC Capital Management's 13F filing for Q4 2025, filed 9 Mar 2026.